Completed Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer NCT00654238 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +20 more Locations University of Pennsylvania - Abramson Comprehensive Cancer Center — Philadelphia, Pennsylvania, United States View Trial Details
Completed Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study NCT01927887 Conditions Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +20 more Locations Massachusetts General Hospital — Boston, Massachusetts, United States View Trial Details
Completed CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice NCT02109250 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more Locations Clinique du Sud Luxembourg — Arlon, Belgium AZ Klina — Brasschaat, Belgium Institut Jules Bordet — Brussels, Belgium UZ Brussel — Brussels, Belgium View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting GFRα4 CAR T Cells in MTC Patients NCT04877613 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +11 more Locations University of Pennsylvania — Philadelphia, Pennsylvania, United States View Trial Details
